Carboplatin + ELRAGLUSIB + Paclitaxel for sarcoma

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 20 Sep 2018: Trial registered, NCT03678883
  2. 4 Jan 2019: Trial started, NCT03678883

The trials

NCT03678883: 9-ING-41 in Patients With Advanced Cancers

State
Under way
Phase
Phase 2
People
350 planned
Started
4 Jan 2019
Primary completion
Jun 2026
Arms
9-ING-41 plus Paclitaxel/Carboplatin
Results
None posted
  1. 20 Sep 2018: Trial registered
  2. 4 Jan 2019: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.